What is Biostrategy Analytics?
Pharma is currently facing various challenges including low R&D productivity and competition from generic drugs. Instead, Biotech suffers from lack of funding more than ever as markets become more and more cautious with sectors showing a high risk profile.
Biostrategy Analytics’s mission is to provide Pharma/Biotech companies with pragmatic analyses and deep insights into the industry.
Investment Associate – Big Pi Ventures
(Dec. 2018 – present)
Big Pi Ventures is a leading VC Fund in Greece focused on investing in deep technology start-ups. Dimitris is involved in evaluating and assessing potential investment opportunities with focus on health-tech start-ups.
Corporate Development Mngr – Genesis Pharma
(Jun. 2015 – Jan. 2017)
At Genesis Pharma, Dimitris was responsible for expanding the company’s portfolio of pharma products by securing in-licensing deals with larger pharmaceutical companies. He was also involved in expanding the company’s operations in other territories.
Consultant – Deloitte
(Feb. 2013 – Dec. 2014)
At Deloitte, Dimitris was involved in sell-side M&A mandates and was involved in all M&A activities such as building information memorandums, valuation models, buyers target list and company profiles.
Consultant – Novumed Life Sciences Consulting
(Jun. 2012 – Nov. 2012)
Performing market and deal analyses to enable Pharma clients’ optimize their investment decision making.
MSc Management of Biotech Companies
Grenoble Ecole de Management (2013)
MSc Social Sciences
London School of Economics (2012)
Imperial College London (2011)
BEng Chemical Engineering
University College London (UCL) (2009)